297 related articles for article (PubMed ID: 26219704)
1. Clinical Forms and Animal Models of Hypophosphatasia.
Salles JP
Subcell Biochem; 2015; 76():3-24. PubMed ID: 26219704
[TBL] [Abstract][Full Text] [Related]
2. Hypophosphatasia: Biological and Clinical Aspects, Avenues for Therapy.
Salles JP
Clin Biochem Rev; 2020 Feb; 41(1):13-27. PubMed ID: 32158059
[TBL] [Abstract][Full Text] [Related]
3. Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene.
Baumgartner-Sigl S; Haberlandt E; Mumm S; Scholl-Bürgi S; Sergi C; Ryan L; Ericson KL; Whyte MP; Högler W
Bone; 2007 Jun; 40(6):1655-61. PubMed ID: 17395561
[TBL] [Abstract][Full Text] [Related]
4. Hypophosphatasia: Biochemical hallmarks validate the expanded pediatric clinical nosology.
Whyte MP; Coburn SP; Ryan LM; Ericson KL; Zhang F
Bone; 2018 May; 110():96-106. PubMed ID: 29360619
[TBL] [Abstract][Full Text] [Related]
5. Pyridoxine challenge reflects pediatric hypophosphatasia severity and thereby examines tissue-nonspecific alkaline phosphatase's role in vitamin B
Whyte MP; Zhang F; Mack KE; Wenkert D; Gottesman GS; Ericson KL; Cole JT; Coburn SP
Bone; 2024 Apr; 181():117033. PubMed ID: 38307176
[TBL] [Abstract][Full Text] [Related]
6. Hypophosphatasia: An overview For 2017.
Whyte MP
Bone; 2017 Sep; 102():15-25. PubMed ID: 28238808
[TBL] [Abstract][Full Text] [Related]
7. Hypophosphatasia: Vitamin B
Whyte MP; Zhang F; Wenkert D; Mack KE; Bijanki VN; Ericson KL; Coburn SP
Bone; 2022 Jan; 154():116204. PubMed ID: 34547524
[TBL] [Abstract][Full Text] [Related]
8. Hypophosphatasia.
Mornet E
Orphanet J Rare Dis; 2007 Oct; 2():40. PubMed ID: 17916236
[TBL] [Abstract][Full Text] [Related]
9. Novel mouse model of autosomal semidominant adult hypophosphatasia has a splice site mutation in the tissue nonspecific alkaline phosphatase gene Akp2.
Hough TA; Polewski M; Johnson K; Cheeseman M; Nolan PM; Vizor L; Rastan S; Boyde A; Pritzker K; Hunter AJ; Fisher EM; Terkeltaub R; Brown SD
J Bone Miner Res; 2007 Sep; 22(9):1397-407. PubMed ID: 17539739
[TBL] [Abstract][Full Text] [Related]
10. Clinical spectrum of hypophosphatasia diagnosed in adults.
Berkseth KE; Tebben PJ; Drake MT; Hefferan TE; Jewison DE; Wermers RA
Bone; 2013 May; 54(1):21-7. PubMed ID: 23352924
[TBL] [Abstract][Full Text] [Related]
11. [Congenital hypophosphatasia].
Terheggen HG; Wischermann A
Monatsschr Kinderheilkd; 1984 Jul; 132(7):512-22. PubMed ID: 6147751
[TBL] [Abstract][Full Text] [Related]
12. Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients.
Whyte MP; Zhang F; Wenkert D; McAlister WH; Mack KE; Benigno MC; Coburn SP; Wagy S; Griffin DM; Ericson KL; Mumm S
Bone; 2015 Jun; 75():229-39. PubMed ID: 25731960
[TBL] [Abstract][Full Text] [Related]
13. Tissue-nonspecific alkaline phosphatase deficiency causes abnormal craniofacial bone development in the Alpl(-/-) mouse model of infantile hypophosphatasia.
Liu J; Nam HK; Campbell C; Gasque KC; Millán JL; Hatch NE
Bone; 2014 Oct; 67():81-94. PubMed ID: 25014884
[TBL] [Abstract][Full Text] [Related]
14. Neurological Symptoms of Hypophosphatasia.
Taketani T
Subcell Biochem; 2015; 76():309-22. PubMed ID: 26219717
[TBL] [Abstract][Full Text] [Related]
15. Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl-/- mice by administration of soluble (non-targeted) chimeric alkaline phosphatase.
Gasque KC; Foster BL; Kuss P; Yadav MC; Liu J; Kiffer-Moreira T; van Elsas A; Hatch N; Somerman MJ; Millán JL
Bone; 2015 Mar; 72():137-47. PubMed ID: 25433339
[TBL] [Abstract][Full Text] [Related]
16. Pyridoxal 5'-phosphate and related metabolites in hypophosphatasia: Effects of enzyme replacement therapy.
Akiyama T; Kubota T; Ozono K; Michigami T; Kobayashi D; Takeyari S; Sugiyama Y; Noda M; Harada D; Namba N; Suzuki A; Utoyama M; Kitanaka S; Uematsu M; Mitani Y; Matsunami K; Takishima S; Ogawa E; Kobayashi K
Mol Genet Metab; 2018 Sep; 125(1-2):174-180. PubMed ID: 30049651
[TBL] [Abstract][Full Text] [Related]
17. Compound heterozygosity of two functional null mutations in the ALPL gene associated with deleterious neurological outcome in an infant with hypophosphatasia.
Hofmann C; Liese J; Schwarz T; Kunzmann S; Wirbelauer J; Nowak J; Hamann J; Girschick H; Graser S; Dietz K; Zeck S; Jakob F; Mentrup B
Bone; 2013 Jul; 55(1):150-7. PubMed ID: 23454488
[TBL] [Abstract][Full Text] [Related]
18. Bone mineralization-dependent craniosynostosis and craniofacial shape abnormalities in the mouse model of infantile hypophosphatasia.
Durussel J; Liu J; Campbell C; Nam HK; Hatch NE
Dev Dyn; 2016 Feb; 245(2):175-82. PubMed ID: 26605996
[TBL] [Abstract][Full Text] [Related]
19. Molecular Genetics of Hypophosphatasia and Phenotype-Genotype Correlations.
Mornet E
Subcell Biochem; 2015; 76():25-43. PubMed ID: 26219705
[TBL] [Abstract][Full Text] [Related]
20. Severe perinatal hypophosphatasia case with a novel mutation.
Yazici H; Canda E; Kalkan Ucar S; Coker M
Arch Argent Pediatr; 2022 Feb; 120(1):e21-e24. PubMed ID: 35068125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
